CN106266548A - 治疗慢性胃炎的中药组合物、制备方法及其中药制剂 - Google Patents
治疗慢性胃炎的中药组合物、制备方法及其中药制剂 Download PDFInfo
- Publication number
- CN106266548A CN106266548A CN201610860818.XA CN201610860818A CN106266548A CN 106266548 A CN106266548 A CN 106266548A CN 201610860818 A CN201610860818 A CN 201610860818A CN 106266548 A CN106266548 A CN 106266548A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 98
- 239000000203 mixture Substances 0.000 title claims abstract description 60
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 53
- 208000023652 chronic gastritis Diseases 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 42
- 241000628997 Flos Species 0.000 claims abstract description 25
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 24
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 24
- 239000009286 sanguis draxonis Substances 0.000 claims abstract description 24
- 241000272522 Anas Species 0.000 claims abstract description 20
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 20
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 20
- 210000004681 ovum Anatomy 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 239000007788 liquid Substances 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 24
- 239000002994 raw material Substances 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 18
- 238000009835 boiling Methods 0.000 claims description 16
- 235000010894 Artemisia argyi Nutrition 0.000 claims description 12
- 244000030166 artemisia Species 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 11
- 239000013521 mastic Substances 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 9
- 230000001684 chronic effect Effects 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 239000002674 ointment Substances 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000002386 leaching Methods 0.000 claims description 5
- 240000000774 Cunila origanoides Species 0.000 claims description 3
- 235000018274 Cunila origanoides Nutrition 0.000 claims description 3
- 235000014866 Dictamnus albus Nutrition 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 240000002853 Nelumbo nucifera Species 0.000 claims description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 abstract description 33
- 210000004369 blood Anatomy 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 28
- 238000002560 therapeutic procedure Methods 0.000 abstract description 27
- 210000000952 spleen Anatomy 0.000 abstract description 22
- 230000001737 promoting effect Effects 0.000 abstract description 12
- 230000036039 immunity Effects 0.000 abstract description 8
- 230000001717 pathogenic effect Effects 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 5
- 208000026435 phlegm Diseases 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 30
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 21
- 201000010099 disease Diseases 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 18
- 230000036407 pain Effects 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 16
- 229940079593 drug Drugs 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 13
- 238000009472 formulation Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000001225 therapeutic effect Effects 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 238000001467 acupuncture Methods 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 241000475481 Nebula Species 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 208000018556 stomach disease Diseases 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 241000272525 Anas platyrhynchos Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000372132 Hydrometridae Species 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 208000007107 Stomach Ulcer Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000035568 catharsis Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000005187 foaming Methods 0.000 description 3
- 239000009969 fructus bruceae Substances 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 201000005917 gastric ulcer Diseases 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 208000001387 Causalgia Diseases 0.000 description 2
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000012895 Gastric disease Diseases 0.000 description 2
- 206010018045 Gastroptosis Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- 241001093501 Rutaceae Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 229940116318 copper carbonate Drugs 0.000 description 2
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000002321 radial artery Anatomy 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 244000089795 Clausena lansium Species 0.000 description 1
- 235000008738 Clausena lansium Nutrition 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000037803 Coptis deltoidea Species 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010017062 Formication Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018873 Haemoconcentration Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020112 Hirsutism Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 241001349804 Juncus alpinoarticulatus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001083838 Lardizabalaceae Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000124079 Mylabris Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- 244000248557 Ophiopogon japonicus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 240000006711 Pistacia vera Species 0.000 description 1
- 235000003447 Pistacia vera Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 240000003085 Quassia amara Species 0.000 description 1
- 235000009694 Quassia amara Nutrition 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000907663 Siproeta stelenes Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229930191701 arteannuin Natural products 0.000 description 1
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 1
- 229960004191 artemisinin Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- -1 fluidizer Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000020233 pistachio Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 description 1
- 229940013788 quassia Drugs 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/342—Adenophora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种治疗慢性胃炎的中药组合物及其制备方法,属于中药制剂技术领域。一种治疗慢性胃炎的中药组合物,由沙参、麦冬、荆芥、防风、毛茛、黄柏、黄连、血竭、三七、铜绿、红花、鸭蛋子、青蒿、白鲜皮和薄荷油制成。本发明中药组合物协同配合,活血化瘀,温阳散寒,扶正祛邪,利湿化痰,健脾和胃,配合天灸疗法,祛扶有度,相得益彰,充分调动人体机能,改变体内瘀滞状态,增强人体免疫力,以预防和彻底治疗慢性胃炎。
Description
技术领域
本发明属于中药制剂技术领域,具体涉及一种治疗慢性胃炎的中药组合物、制备方法及其中药制剂。
背景技术
慢性胃炎是指各种因素引起的慢性胃黏膜炎性病变,大多数患者表现为上腹部饱胀或疼痛、嗳气等。本病是消化内科常见和多发病之一,其发病率极高,在各种胃病中居于首位,约占接受胃镜检查患者的90%以上,对人类健康的影响较大。
慢性胃炎并无独立的中医病名,临床上大多数可有典型的症状如上腹痛或不适、上腹胀、嗳气、反酸,亦可无症状。根据其症状将其归于中医学“胃痛”、“痞满”、“吐酸”、“嘈杂”等范畴。本病多因感受外邪、饮食伤胃、情志失调、脾胃素虚所致,其病位在胃,与肝、脾的关系极为密切。肝主疏泄,调畅气机,协调脾胃升降,有助于食物的消化与吸收,故《素问·宝命全形论篇》说:“土得木而达”。肝与胃在生理上密切相关,病理上必然相互影响。若情志不遂,肝郁气滞,横逆犯胃,致中焦气机阻滞、脾胃运化失司,则为肝胃不和;气郁化热,热灼津液,日久又可导致胃阴不足;脾胃运化失司,食反为滞,则食积不化;水反为湿,湿郁化热,则湿热内蕴脾胃;气滞日久可致血瘀或久病入络,则出现胃络血瘀;可见,肝的疏泄功能在本病发病过程中起了极其重要的作用。正如《血证论·脏腑病机论》所说:“木之性主于疏泄,食气入胃,全赖肝木气以疏泄之,而水谷乃化,设肝之清阳不升,则不能疏泄水谷,渗湿中满之证,在所不免”。脾与胃同为中焦,互为表里,脾主运化,胃主受纳、脾升胃降,两者密切合作,同为气血生化之源、后天之本。脾失健运可导致胃纳不振,而胃气失和,也可导致脾运失常。正如《注解伤寒论》所说:“脾,坤土也。脾助胃气消磨水谷,脾气不转,则胃中水谷不得消磨”,故脾病多涉于胃,胃病亦可及于脾,出现脾胃同病。
目前一般采用对症治疗,无特效治疗方法,且复发率高。传统医学的天灸疗法是采用刺激性药物敷贴于皮肤表面,致使局部充血发泡,激发经络气血运行,起到调整机体免疫的作用。天灸疗法属于现代医学意义上的经皮给药系统疗法,即指在皮肤表面使药物以恒定速度(或接近恒定速度)通过皮肤各层,进入体循环产生全身或局部治疗作用的疗法。经皮给药可以不经过肝脏的“首过效应”和胃肠道的破坏;皮肤间层有贮存作用,使药物浓度曲线平缓,避免了“峰谷现象”,提供可预定和较长的作用时间,维持稳定持久的血液浓度;毒性和不良反应小;用药部位在体表,中断给药方便。
江莉君(江莉君.天灸治疗脾胃虚寒型慢性浅表性胃炎30例总结[J].湖南中医杂志,2016,32(1):69-70)将60例脾胃虚寒型慢性浅表性胃炎患者随机分为治疗组及对照组各30例,治疗组以天炙贴敷治疗,对照组以西药治疗,疗程4周,比较两组临床疗效,结果为总有效率治疗组为96.67%,对照组为83.33%,两组比较,差异有统计学意义(P<0.05),并得出结论:天灸治疗脾胃虚寒型慢性浅表性胃炎的疗效优于西药治疗。申请号为201010175067.0的专利公开了一种用于治疗慢性萎缩性胃炎的舒胃发泡膏及其制备方法,是将生半夏、吴茱萸、生南星、乌药和斑蝥,分别清洗,烘干,粉碎,过100目筛,然后与鲜姜汁一起经紫外线杀菌,按比例混合制成膏泥状,进而制成药贴,然后直接敷贴于患者脾俞、胃俞穴上后采用发泡疗法治疗慢性萎缩性胃炎。该发明的舒胃发泡膏通过中药发泡技术的应用既能达到局部的穴位刺激治疗作用,又能使药物的活性因子通过皮肤的渗透直达病所,起到中药多靶点激活多系统参与治疗病灶的作用,临床试验表明,效果显著。
天灸疗法作为中华瑰宝之一,尽管现有诸多研究表明其在治疗消化系统疾病方面具有较好的疗效,但是其还未发挥出真正的价值,尤其是对慢性胃炎的治疗效果方面还有待提高。
发明内容
有鉴于此,本发明所要解决的技术问题是提供一种中药组合物,采用天灸疗法,能够显著缓解、消除或改善由慢性胃炎引起的一系列不适病症,从根源上改善患者体质,消除体内瘀滞状态,提高人体免疫力,增强人体对疾病的抵抗能力,从而实现从根本上治疗慢性胃炎的目的。
为实现上述目的,本发明所采用的技术方案是:
一种治疗慢性胃炎的中药组合物,由如下重量份的原料制成:沙参10~20份、麦冬7~15份、荆芥5~15份、防风5~15份、毛茛10~20份、黄柏5~12份、黄连10~15份、血竭5~15份、三七1~7份、铜绿1~5份、红花5~15份、鸭蛋子3~10份、青蒿3~12份、白鲜皮1~5份、薄荷油5~15份。
优选地,所述治疗慢性胃炎的中药组合物,由如下重量份的原料制成:沙参12~15份、麦冬8~12份、荆芥8~12份、防风10~15份、毛茛12~15份、黄柏6~10份、黄连10~12份、血竭10~15份、三七2~5份、铜绿3~5份、红花10~15份、鸭蛋子5~8份、青蒿5~10份、白鲜皮2~4份、薄荷油8~12份。
优选地,所述治疗慢性胃炎的中药组合物,由如下重量份的原料制成:沙参12份、麦冬10份、荆芥10份、防风12份、毛茛15份、黄柏8份、黄连10份、血竭12份、三七4份、铜绿4份、红花12份、鸭蛋子6份、青蒿8份、白鲜皮3份、薄荷油10份。
一种上述治疗慢性胃炎的中药组合物的制备方法,包括如下步骤:
步骤S1:分别称取荆芥、防风、黄柏、黄连、血竭、三七、铜绿、红花、鸭蛋子、青蒿、白鲜皮、沙参和麦冬,混合,加水煎煮,加水的体积与所述中药组合物的质量以20~30ml:1g进行计量;
步骤S2:首先武火煎煮10~20分钟,然后文火煎煮30~50分钟,趁热过滤,得到煎液;
步骤S3:将所得煎液进行减压浓缩,温度为50~80℃,压力为5~10kPa,得到浸膏,所述浸膏的相对密度为1.3~1.5;
步骤S4:将毛茛捣成糊状,加入薄荷油,与所述浸膏混合均匀,得到膏体。
一种上述治疗慢性胃炎的中药组合物的制备方法,包括以下步骤:
步骤S1:分别称取荆芥、防风、毛茛、黄柏、黄连、血竭、三七、铜绿、红花、鸭蛋子、青蒿、白鲜皮、薄荷油、沙参和麦冬,混合,加水煎煮,加水的体积与所述中药组合物的质量以15~25ml:1g进行计量;
步骤S2:首先武火煎煮10~15分钟,然后文火煎煮30~40分钟,趁热过滤,得到煎液;
步骤S3:将所得煎液进行减压浓缩,温度为55~65℃,压力为5~6kPa,得到浸膏,所述浸膏的相对密度为1.1~1.3;
步骤S4:将所述浸膏进行真空干燥,粉碎,得到粉体。
一种治疗慢性胃炎的中药制剂,以上述中药组合物为有效成分,制备成水剂、膏剂、粉剂或片剂。
优选地,所述治疗慢性胃炎的中药组合物,还包括以下重量份的原料Ⅱ:薏苡仁8~12份、艾芽8~12份、山药8~12份、郁金8~12份、白术8~12份、茯苓8~12份。
优选地,所述原料Ⅱ通过下述方法进行制备,具体为:分别称取薏苡仁8~12g、艾芽8~12g、山药8~12g、郁金8~12g、白术8~12g和茯苓8~12g,混合加水,每克所述原料加水10~12ml,添加姜片5g,微波加热,提取2~3次,每次提取1~2小时,合并提取液,过滤,滤液浓缩至70~80℃时相对密度为1.17~1.19的浸膏;在所述浸膏中加入体积分数为75~80%的乙醇溶液,静置20~24小时,再次过滤,滤液浓缩至75℃时相对密度为1.14~1.15的膏体;将所述膏体干燥,超微粉碎,得到超微粉。
荆芥:味辛,微温;归肺、肝经。主治解表散风,透疹。用于感冒,头痛,麻疹,风疹,疮疡初起。荆芥炮制方法为:除去杂质,喷淋清水,洗净,润透,切段,晒干。
防风:味辛、甘,温。归膀胱、肝、脾经。主治解表祛风,胜湿,止痉。具有镇痛、抗菌、解热等作用。
毛茛:为毛茛科植物毛茛的全草及根,又名天灸草、自灸草和毛芹草等,味辛,性温,有毒。外用可以刺激皮肤起泡。主治利湿,消肿,止痛,退翳,截疟,杀虫。用于胃痛,黄疸,疟疾,淋巴结结核,翼状胬肉、角膜云翳,灭蛆、杀孑孓。《本草纲目》曰“蓑乃草乌头之苗,俗名毛荃,似水荃而有毛也,采其叶揉按寸口部位,一夜即发泡如火燎,故呼为天灸或自灸。”又载“山人截疟,采叶按贴寸口,一夜作泡如火燎。
黄柏:为芸香科植物黄檗或黄皮树的树皮。味苦,寒;主治清热,燥湿,泻火,解毒。治热痢,泄泻,消渴,黄疸,痿躄,梦遗,淋浊,痔疮,便血,亦白带下,骨蒸劳热,目赤肿痛,口舌生疮,疮疡肿毒。黄柏中含有较多的小檗碱,能够有效抗菌。体外试验对金黄色葡萄球菌、肺炎球菌、白喉杆菌、草绿色链球菌、痢疾杆菌(宋内氏除外)等均有效。
黄连:为毛茛科植物黄连、三角叶黄连或云连的干燥根茎。主治清热燥湿,泻火解毒。具有抗菌、抗感染、抗炎症等多种功效。与黄连复配使用,可以提高抗菌效果。
血竭:又名大血藤,为木通科植物大血藤的茎。主治活血通经,祛风除湿。据《中华本草》记载,血竭含大黄素,大黄素甲醚,β-谷甾醇,胡萝卜甙,硬脂酸,毛柳甙,右旋丁香树脂酚二葡萄糖甙等成分,对心血管具有一定的影响。
三七:为五加科植物三七的干燥根。主治散瘀止血,消肿定痛。用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹剌痛,跌扑肿痛。药理作用研究表明,三七块根流浸膏能缩短家兔血液凝固时间,有止血作用;有增加冠状动脉血流量,减慢心率,减少心肌氧消耗的作用,并能对抗因脑垂体后叶素所致的血压升高、冠状动脉收缩的作用。
铜绿:为铜氧化生成的碱式碳酸铜或天然的孔雀石,主含碱式碳酸铜。味酸涩,平,有毒。主治退翳,去腐,敛疮,杀虫,吐风痰。治目翳,烂弦风眼,疽、痔恶疮,喉痹,牙疳,臁疮,顽癣,风痰卒中。铜绿与其他物质反应后变成铜离子,使细菌内蛋白质变性,从而使细菌体死亡。
红花:为菊科植物红花的干燥花。主治活血通经,去瘀止痛。治经闭,症瘕,难产,死胎,产后恶露不行、瘀血作痛,痈肿,跌扑损伤。
鸭蛋子:又名鸦胆子,为苦木科植物鸦胆子的果实。味苦;性寒;小毒。主治清热;解毒;杀虫;截疟。《医学衷中参西录》记载,鸦胆子,性善凉血止血,兼能化瘀生新。
青蒿:味苦、辛,寒。主治清热,解暑,除蒸。含有苦味质、挥发油和青蒿碱、维生素A。《中华本草》记载,青蒿水煎液对表皮葡萄球菌、卡他球菌、炭疽杆菌、白喉杆菌有较强的抑菌作用,对金黄色葡萄球菌、绿脓杆菌、痢疾杆菌、结核秆菌等也有一定的抑制作用。青蒿素还可以减慢心率,抑制心肌收缩力,降低冠脉流量。
白鲜皮:芸香科植物白鲜的干燥根皮。味苦;咸;寒。主治清热燥湿;祛风止痒;解毒。主风热湿毒所致的风疹;湿疹;疥癣;黄疸;湿热痹。
薄荷油:来源于薄荷的新鲜茎和叶,将薄荷茎、叶晒至半干,即可蒸馏,得薄荷油。薄荷油为淡草绿色液体或淡黄色的澄清液体,具有强烈的薄荷香气和清凉的微苦味。薄荷油中主成分为左旋薄荷醇含量62.3%-87.2%。可用作芳香药、调味药及驱风药。用于风热感冒,温病初起;肝郁气滞,胸闷胁痛;头痛目赤,咽喉肿痛等症。
沙参:别名南沙参、泡参、泡沙参。性味味甘;微苦;性微寒;归肺、胃经;主治养阴清热;润肺化痰;益胃生津;主阴虚久咳;痨嗽痰血;燥咳痰少;虚热喉痹;津伤口渴。
麦冬:百合科沿阶草属多年生常绿草本植物,根较粗,中间或近末端常膨大成椭圆形或纺锤形的小块根。《医学衷中参西录》言其:“能入胃以养胃液,开胃进食,更能入脾以助脾散精于肺,定喘宁嗽。”中医认为,麦冬味甘、微苦,性微寒,归胃、肺、心经,有养阴润肺、益胃生津、清心除烦的功效,用于肺燥干咳、阴虚痨嗽、喉痹咽痛、津伤口渴、内热消渴、心烦失眠、肠燥便秘等症。
与现有技术相比,本发明的有益效果如下:
1)本发明申请人对天灸疗法深有研究,并通过多年民间实践提出了一种能够治疗慢性胃炎的天灸中药组合物。本发明以中医理论为指导,本着“治病求本”的原则,将内治外治的原理相互贯通,实现理论与实践的统一。本发明通过药物协同,从根源上改善患者体质,化解体内瘀滞状态,提高人体免疫能力,并结合天灸疗法的独特优势,反复研究施治药剂,使之与皮肤产生适度刺激,改善皮肤通透性,使药性从毛孔而入腠理,通经贯络,直达病灶,增强人体对疾病的抵抗能力,从而达到彻底治疗慢性胃炎的目的。
2)本发明中药组合物协同配合,活血化瘀,温阳散寒,扶正祛邪,利湿化痰,健脾和胃,配合天灸疗法,祛扶有度,相得益彰,充分调动人体机能,改变体内瘀滞状态,增强人体免疫力,以预防和彻底治疗慢性胃炎。
3)本发明组方科学,配伍合理,诸药协同,扶正祛邪,标本兼治。而且,本发明的使用方法是将中药组合物涂/敷于皮肤表层或穴位,使其局部皮肤灼热、潮红,继之起泡,再结合天灸疗法,通过皮肤表面的毛孔扩张,加强药物分子的快速渗透,和/或通过穴位对药物的外敏性、放大性和储存性以及穴位的双向调节性,实现针刺与药物的协同效果,使药物分子能够直达病灶。中医认为,各种疾病的发生,都是由于致病因素作用于人体,导致人体阴阳、气血、脏腑、经络功能活动失常,造成机体内环境相对平衡状态的破坏所致。本发明中药组合物配合天灸能调整机体免疫功能和内在平衡,增强机体的抗病能力,从根本上改善慢性胃炎的症状,起到事半功倍的效果。
4)本发明结合药物特性及用药特点,制备方法简单,易于操作,普适性广,所得药物疗效显著,易于制作成不同剂型的外用药。
5)本发明以薏苡仁、艾芽、山药、郁金、白术和茯苓作为口服制剂搭配天灸使用,口服制剂以超微粉的形式进行真空包装,使用时直接加水溶解即可,一袋超微粉10~12g,一次冲200ml直接口服。其中,薏苡仁、艾芽、山药、郁金、白术和茯苓配伍相宜,通过适当方法提取,口服具有健胃消食,平肝理气,调节免疫的作用,与天灸疗法配合,更有利于患者病情的快速恢复,达到标本兼治的目的。
具体实施方式
为了更好地理解本发明,下面结合实施例进一步清楚阐述本发明的内容,但本发明的保护内容不仅仅局限于下面的实施例。在下文的描述中,给出了大量具体的细节以便提供对本发明更为彻底的理解。然而,对于本领域技术人员来说显而易见的是,本发明可以无需一个或多个这些细节而得以实施。
实施例1:一种治疗慢性胃炎的中药组合物,由如下重量份配比的原料制成:荆芥10份、防风12份、毛茛15份、黄柏8份、黄连10份、血竭12份、三七4份、铜绿4份、红花12份、鸭蛋子6份、青蒿8份、白鲜皮3份、薄荷油10份、沙参12份、麦冬10份。
实施例2:一种治疗慢性胃炎的中药组合物,由如下重量份配比的原料制成:荆芥8份、防风10份、毛茛12份、黄柏6份、黄连12份、血竭10份、三七2份、铜绿3份、红花10份、鸭蛋子5份、青蒿5份、白鲜皮2份、薄荷油8份、沙参14份、麦冬8份。
实施例3:一种治疗慢性胃炎的中药组合物,由如下重量份配比的原料制成:荆芥12份、防风15份、毛茛14份、黄柏10份、黄连10份、血竭15份、三七5份、铜绿5份、红花15份、鸭蛋子8份、青蒿10份、白鲜皮4份、薄荷油12份、沙参15份、麦冬12份。
实施例4:一种治疗慢性胃炎的中药组合物,由如下重量份配比的原料制成:荆芥15份、防风8份、毛茛20份、黄柏12份、黄连15份、血竭8份、三七7份、铜绿2份、红花8份、鸭蛋子10份、青蒿12份、白鲜皮5份、薄荷油15份、沙参20份、麦冬15份。
实施例5:一种治疗慢性胃炎的中药组合物,由如下重量份配比的原料制成:荆芥5份、防风5份、毛茛10份、黄柏5份、黄连10份、血竭5份、三七1份、铜绿1份、红花5份、鸭蛋子3份、青蒿3份、白鲜皮1份、薄荷油5份、沙参10份、麦冬7份。
实施例6:一种治疗慢性胃炎的中药组合物,由如下重量份配比的原料制成:荆芥10份、防风12份、毛茛15份、黄柏8份、黄连10份、血竭12份、三七4份、铜绿4份、红花12份、鸭蛋子6份、青蒿8份、白鲜皮3份、薄荷油10份、沙参12份、麦冬10份、川芎7份。
本实施例增添川芎一味中药,川芎性温,味辛,归肝、胆、心包经,具有活血行气、祛风止痛之功,与血竭、三七、红花和鸭蛋子协同配伍,加强本方活血化瘀之功效,增强血液循环,补给营养,提高治疗效率。
实施例7:水剂的制备
水剂的制备方法,包括以下步骤:
步骤S1:称取荆芥10g、防风12g、毛茛15g、黄柏8g、黄连10g、血竭12g、三七4g、铜绿4g、红花12g、鸭蛋子6g、青蒿8g、白鲜皮3g、薄荷油10g、沙参12g和麦冬10g,混合,加水煎煮,加水的体积与所述中药组合物的质量以20ml:1g进行计量;
步骤S2:首先武火煎煮12分钟,然后文火煎煮35分钟,趁热过滤,得到煎液。
将所述煎液冷却,可作为水剂直接使用。将水剂无菌储存在喷雾瓶中,喷涂使用更方便。
实施例8:膏剂的制备
膏剂的制备方法包括如下步骤:
步骤S1:称取荆芥10g、防风12g、毛茛15g、黄柏8g、黄连10g、血竭12g、三七4g、铜绿4g、红花12g、鸭蛋子6g、青蒿8g、白鲜皮3g、薄荷油10g、沙参12g和麦冬10g,混合,加水煎煮,加水的体积与所述中药组合物的质量以25ml:1g进行计量;
步骤S2:首先武火煎煮10分钟,然后文火煎煮40分钟,趁热过滤,得到煎液;
步骤S3:将所得煎液进行减压浓缩,温度为65℃,压力为5kPa,得到浸膏,所述浸膏的相对密度为1.2。
所得浸膏可作为膏剂直接使用。
实施例9:膏剂的制备
膏剂的制备方法,包括如下步骤:
步骤S1:称取荆芥10g、防风12g、黄柏8g、黄连10g、血竭12g、三七4g、铜绿4g、红花12g、鸭蛋子6g、青蒿8g、白鲜皮3g、薄荷油5g、沙参12g和麦冬10g,混合,加水煎煮,加水的体积与所述中药组合物的质量以25ml:1g进行计量;
步骤S2:首先武火煎煮15分钟,然后文火煎煮45分钟,趁热过滤,得到煎液。
步骤S3:将所得煎液进行减压浓缩,温度为70℃,压力为8kPa,得到浸膏,所述浸膏的相对密度为1.4;
步骤S4:称取毛茛15g捣成糊状,加入薄荷油5g,与所述浸膏混合均匀,得到膏体。
所得膏体则可作为膏剂直接使用。
实施例10:粉剂的制备
粉剂的制备方法,包括以下步骤:
步骤S1:称取荆芥10g、防风12g、毛茛15g、黄柏8g、黄连10g、血竭12g、三七4g、铜绿4g、红花12g、鸭蛋子6g、青蒿8g、白鲜皮3g、薄荷油10g、沙参12g和麦冬10g,混合,加水煎煮,加水的体积与所述中药组合物的质量以15ml:1g进行计量;
步骤S2:首先武火煎煮20分钟,然后文火煎煮30分钟,趁热过滤,得到煎液。
步骤S3:将所得煎液进行减压浓缩,温度为60℃,压力为6kPa,得到浸膏,所述浸膏的相对密度为1.3;
步骤S4:将所述浸膏进行真空干燥,粉碎,得到粉体。
所得粉体在使用时,需用无菌水或酒精稀释成溶液状,再进行涂抹。
实施例11:片剂的制备
片剂的制备方法,包括如下步骤:
步骤S1~S3同实施例10;
步骤S4:将所述浸膏制成厚度为1~2毫米、直径为0.5~1厘米的片剂。
本发明的述及的一种中药制剂,以上述中药组合物为有效成分,制备成水剂、膏剂、粉剂或片剂,优选为水剂。
上述剂型并非对本发明可制备剂型的穷举,根据本发明及常规工艺,本领域技术人员可以将本发明的药物组合物通过与适宜的载体、赋形剂及稀释剂一同配制为适宜的剂型。所述的剂型还可以为丸剂、散剂、酊剂、混悬剂、乳剂或气雾剂的形式。所述的适宜的载体、赋形剂及稀释剂的实例为淀粉、蔗糖、乳糖、葡萄糖、明胶、山梨醇、甘露醇、硅酸钙、纤维素、甲基纤维素、微晶纤维素、聚乙烯吡咯烷酮、水、羟苯甲酯、羟苯丙酯、滑石、硬脂酸镁和矿物油。所述的剂型中还可另外包括填充剂、抗凝集剂、崩解剂、助流剂、润湿剂、乳化剂、防腐剂等。
实施例12:口服制剂
本发明治疗慢性胃炎的中药组合物,还包括以下重量份的原料Ⅱ:薏苡仁10g、艾芽10g、山药10g、郁金10g、白术10g和茯苓10g。
本实施例所述原料Ⅱ通过下述方法制备成口服制剂,具体为:分别称取薏苡仁10g、艾芽10g、山药10g、郁金10g、白术10g和茯苓10g,混合加水,每克原料加水10ml,添加姜片5g,微波加热,提取2次,每次提取1.5小时,合并提取液,过滤,滤液浓缩至75℃时相对密度为1.18的浸膏;在所述浸膏中加入体积分数为75%的乙醇溶液,静置24小时,再次过滤,滤液浓缩至75℃时相对密度为1.15的膏体;将所述膏体干燥,超微粉碎,得到超微粉。
将超微粉进行真空装袋,每袋装10~12g。使用时,一袋超微粉加200ml水溶解,即为口服制剂。
其中,薏苡仁有利水渗透湿,健脾止泻,除痹,排脓,解毒散结的作用。艾芽取自艾草的新鲜芽尖,采摘于清明节后15天内;具有苦燥 辛散,能够温经脉、理气血、止冷痛、逐寒湿等诸多功效。山药,具有滋养强壮,助消化,敛虚汗,止泻之功效。郁金,活血止痛,行气解郁,清心凉血,利胆退黄。白术,具有健脾益气,燥湿利水,止汗,安胎的功效。茯苓,具有利水渗湿,健脾,宁心之功效。姜片具有利胆、健胃止呕、辟腥臭、消水肿的作用,保健功效显著。上述药物同用,具有健胃消食,平肝理气,调节免疫的功效,采用适宜的制备方法将药物活性成分提取得更加充分。
本发明中,微波加热的功率优选为350~400W,加热温度为70~80℃,通过微波加热更有利于中药的渗透和提取。
是否需要使用口服制剂以患者自身症状进行辩证施治,并非所有患者都需要配合口服。当然对于症状严重的患者,口服更有利于其恢复自身机能,加快治疗效率。
实施例13
本发明治疗慢性胃炎的中药组合物,还包括以下重量份的原料Ⅱ:薏苡仁12g、艾芽10g、山药10g、郁金8g、白术12g和茯苓10g。
本实施例所述原料Ⅱ通过下述方法制备成口服制剂,具体为:分别称取薏苡仁12g、艾芽10g、山药10g、郁金8g、白术12g和茯苓10g,混合加水,每克原料加水12ml,添加姜片5g,微波加热,提取3次,每次提取2小时,合并提取液,过滤,滤液浓缩至78℃时相对密度为1.19的浸膏;在所述浸膏中加入体积分数为80%的乙醇溶液,静置22小时,再次过滤,滤液浓缩至75℃时相对密度为1.14的膏体;将所述膏体干燥,超微粉碎,得到超微粉。
下面以实施例7制备的水剂为例说明本发明中药组合物的使用方法,具体包括如下步骤:
1)将水剂均匀喷涂在皮肤表层或穴位处,轻拍片刻,用无菌膜将涂抹部位包裹,进行固定;2)10~20分钟后,患者可以感觉到局部灼痛、蚁走感,皮肤潮红;3天内,患者皮肤逐渐起泡,待水泡内液体充盈、胀满时,使用天灸疗法,将上述水泡内液体吸出;3)灸疗结束后,对发泡部位进行适度消毒处理。
上述方法治疗一次为1个疗程,根据病情的严重程度,一周施诊1~2次,遵医嘱。
本发明天灸药剂以药物本身进行抗菌,防感染,与现有天灸药剂相比,不添加任何化学试剂,对皮肤无毒性,而且抗菌、防感染效果优异,无需担心发泡部位感染问题;本发明操作过程较现有方法更加简单,易于把控,甚至可以自行在家治疗。
天灸疗法使药物作用于皮肤表面产生的物理性刺激,进而刺激人体经络系统,引起交感神经反射弥散,使得经络脏腑机能的调节,起到治疗作用。长期实践表明,本发明通过刺澈体表的皮部并结合天炙药物的作用,从根源上治疗慢性胃炎,疗效更彻底,疗程更短,效果优异。而且,经皮给药具有超越一般给药方法的独特优点,可以不经过肝脏的“首过效应”和胃肠道的破坏,且皮肤间层还有储存作用,使药物浓度曲线平缓,避免了峰谷现象,提供可预定的和较长的作用时间,维持稳定持久的血药浓度,毒性和不良反应小,使用方便,贴敷者可以自行给药和随时中止用药。
1、本发明中药组合物的疗效观察
观察病例:2013年4月~2015年9月期间完成相应治疗疗程的慢性胃炎患者;可列入观察的共有200例。
诊断标准:参照《慢性胃炎中西医结合诊疗共识意见》拟定。胃镜可见红斑(点状、片状和条状)、黏膜粗糙不平,出血点(斑),黏膜水肿、出血等基本表现;活检符合慢性浅表性胃炎的表现。脾胃虚寒证型主症:胃脘隐痛,喜按喜暖。次症:(1)食后胀满;(2)纳呆少食;(3)大便稀溏;(4)神疲乏力;(5)舌质淡有齿痕,苔薄白;(6)脉沉细。证型确定:具备主症2项加次症1项,或主症第1项加次症2项,并结合胃镜确诊。
治疗方法:方法Ⅰ:采用本发明水剂以天灸疗法进行治疗,每周1~2次,连续使用2个月。方法Ⅱ:采用本发明水剂以天灸疗法进行治疗,同方法Ⅰ;同时服用口服制剂,每次天灸疗法配合一副口服制剂200ml。将200例患者随机分成两组,采用方法Ⅰ治疗120例,采用方法Ⅱ治疗80例,两组之间无显著性差异。
疗效标准:疗效标准参照《慢性胃炎中西医结合诊疗共识意见》拟定。痊愈:症状及体征消失或基本消失;显效:症状及体征明显改善;有效:症状及体征好转;无效:未达到上述标准者。
统计结果:本发明在临床上取得了非常好的疗效,在200例慢性胃炎患者中,采用方法Ⅰ治疗的120例患者中,痊愈105例,显效10例,显效率95.8%;好转5例,总有效率为100%。采用方法Ⅱ治疗的80例患者中,痊愈73例,显效7例,显效率为100%。
上述对比可以看到,采用方法Ⅰ和方法Ⅱ治疗的总有效率均为100%,不同的是:采用治疗方法Ⅱ更有利于患者的痊愈,显效率稍高。此外,申请人对痊愈患者的治疗时间进行了比对,发现采用治疗方法Ⅱ进行治疗,患者的疗程可以缩短2~3个疗程的时间。
此外,本发明除对慢性胃炎疗效显著外,对胃溃疡、胃结石和胃下垂等胃部疾病也有很好的疗效,申请人统计显示,2013年4月~2015年9月期间完成相应的治疗的患者中,仅采用天灸疗法,胃溃疡64例,显效率91%,总有效率100%;胃结石32例,显效率89%,总有效率100%;胃下垂59例,显效率92%,总有效率100%。上述结果表明,本发明天灸疗法对胃部疾病具有较好的治疗效果。
2、本发明所述中药组合物的临床观察
案例1:姜某,男,32岁,在职工人,患慢性胃炎2年,经常感觉胃脘胀满疼痛、胁肋胀痛,情志抑郁、胸闷、食少。采用本发明所述中药组合物进行天灸疗法治疗1个月后,相关症状基本消失,指标恢复正常。
案例2:李某,女,52岁,在职工人,患慢性胃炎1年半,胃脘胀满,四肢乏力,舌体胖,大有齿印,苔薄白,面色萎黄,气短。采用本发明所述中药组合物进行天灸疗法治疗2周后,上述症状明显改善,患者精神状态良好。
案例3:李某,女,27岁,学生,患慢性胃炎2年半,胃脘胀满疼痛,痛有定处而拒按,舌质紫黯,脉涩,采用西医治疗半年有余,效果不佳。采用本发明所述中药组合物进行天灸疗法治疗2个月后,胃部炎症得到控制,且相关指标恢复正常,胃部不再胀痛,患者精神状态良好。
案例4:齐某,男,46岁,在职工人,患胃溃疡3年多,饥饿时胃部常常出现胀痛、灼痛感觉,反酸,进食后缓解,患者精神状态差,食欲差,失眠西医治疗1年多,未得到有效控制。采用本发明所述中药组合物进行天灸疗法治疗2个月后,胃部痛感消失,饥饿时的不适感消失,食欲恢复,可正常进食,精神状态良好。
上述案例仅为本发明部分施诊病例,情况属实,记载在本文中仅用于说明本发明的部分具体适应症,但是本发明并不局限于上述病例所反映的症状。本领域技术人员根据本文的内容结合常规知识将其用于其他疾病的治疗,也包含在本发明的保护范围内。
最后说明的是,以上实施例仅用以说明本发明的技术方案而非限制,本领域普通技术人员对本发明的技术方案所做的其他修改或者等同替换,只要不脱离本发明技术方案的精神和范围,均应涵盖在本发明的权利要求范围当中。
Claims (8)
1.一种治疗慢性胃炎的中药组合物,其特征在于:由如下重量份的原料制成:沙参10~20份、麦冬7~15份、荆芥5~15份、防风5~15份、毛茛10~20份、黄柏5~12份、黄连10~15份、血竭5~15份、三七1~7份、铜绿1~5份、红花5~15份、鸭蛋子3~10份、青蒿3~12份、白鲜皮1~5份、薄荷油5~15份。
2.如权利要求1所述的治疗慢性胃炎的中药组合物,其特征在于:由如下重量份的原料制成:沙参12~15份、麦冬8~12份、荆芥8~12份、防风10~15份、毛茛12~15份、黄柏6~10份、黄连10~12份、血竭10~15份、三七2~5份、铜绿3~5份、红花10~15份、鸭蛋子5~8份、青蒿5~10份、白鲜皮2~4份、薄荷油8~12份。
3.如权利要求2所述的治疗慢性胃炎的中药组合物,其特征在于:由如下重量份的原料制成:沙参12份、麦冬10份、荆芥10份、防风12份、毛茛15份、黄柏8份、黄连10份、血竭12份、三七4份、铜绿4份、红花12份、鸭蛋子6份、青蒿8份、白鲜皮3份、薄荷油10份。
4.一种如权利要求1~3任一项所述的治疗慢性胃炎的中药组合物的制备方法,其特征在于:包括如下步骤:
步骤S1:分别称取荆芥、防风、黄柏、黄连、血竭、三七、铜绿、红花、鸭蛋子、青蒿、白鲜皮、沙参和麦冬,混合,加水煎煮,加水的体积与所述中药组合物的质量以20~30ml:1g进行计量;
步骤S2:首先武火煎煮10~20分钟,然后文火煎煮30~50分钟,趁热过滤,得到煎液;
步骤S3:将所得煎液进行减压浓缩,温度为50~80℃,压力为5~10kPa,得到浸膏,所述浸膏的相对密度为1.3~1.5;
步骤S4:将毛茛捣成糊状,加入薄荷油,与所述浸膏混合均匀,得到膏体。
5.一种如权利要求1~3任一项所述的治疗慢性胃炎的中药组合物的制备方法,其特征在于,包括以下步骤:
步骤S1:分别称取荆芥、防风、毛茛、黄柏、黄连、血竭、三七、铜绿、红花、鸭蛋子、青蒿、白鲜皮、薄荷油、沙参和麦冬,混合,加水煎煮,加水的体积与所述中药组合物的质量以15~25ml:1g进行计量;
步骤S2:首先武火煎煮10~15分钟,然后文火煎煮30~40分钟,趁热过滤,得到煎液;
步骤S3:将所得煎液进行减压浓缩,温度为55~65℃,压力为5~6kPa,得到浸膏,所述浸膏的相对密度为1.1~1.3;
步骤S4:将所述浸膏进行真空干燥,粉碎,得到粉体。
6.一种治疗慢性胃炎的中药制剂,其特征在于:以权利要求1~3任一项所述的治疗慢性胃炎的中药组合物为有效成分,制成水剂、膏剂、粉剂或片剂。
7.如权利要求1~3任一项所述的治疗慢性胃炎的中药组合物,其特征在于:还包括以下重量份的原料Ⅱ:薏苡仁8~12份、艾芽8~12份、山药8~12份、郁金8~12份、白术8~12份、茯苓8~12份。
8.如权利要求7所述的治疗慢性胃炎的中药组合物,其特征在于:所述原料Ⅱ通过下述方法进行制备,具体为:分别称取薏苡仁8~12g、艾芽8~12g、山药8~12g、郁金8~12g、白术8~12g和茯苓8~12g,混合加水,每克所述原料加水10~12ml,添加姜片5g,微波加热,提取2~3次,每次提取1~2小时,合并提取液,过滤,滤液浓缩至70~80℃时相对密度为1.17~1.19的浸膏;在所述浸膏中加入体积分数为75~80%的乙醇溶液,静置20~24小时,再次过滤,滤液浓缩至75℃时相对密度为1.14~1.15的膏体;将所述膏体干燥,超微粉碎,得到超微粉。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610860818.XA CN106266548A (zh) | 2016-09-29 | 2016-09-29 | 治疗慢性胃炎的中药组合物、制备方法及其中药制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610860818.XA CN106266548A (zh) | 2016-09-29 | 2016-09-29 | 治疗慢性胃炎的中药组合物、制备方法及其中药制剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106266548A true CN106266548A (zh) | 2017-01-04 |
Family
ID=57716516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610860818.XA Pending CN106266548A (zh) | 2016-09-29 | 2016-09-29 | 治疗慢性胃炎的中药组合物、制备方法及其中药制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106266548A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112353863A (zh) * | 2020-09-23 | 2021-02-12 | 鲁南制药集团股份有限公司 | 荆防制剂在制备治疗胃溃疡药物中的应用及其制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1078645A (zh) * | 1993-04-20 | 1993-11-24 | 谢民福 | 外用消炎油及其配制方法 |
-
2016
- 2016-09-29 CN CN201610860818.XA patent/CN106266548A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1078645A (zh) * | 1993-04-20 | 1993-11-24 | 谢民福 | 外用消炎油及其配制方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112353863A (zh) * | 2020-09-23 | 2021-02-12 | 鲁南制药集团股份有限公司 | 荆防制剂在制备治疗胃溃疡药物中的应用及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101926900B (zh) | 一种足浴组合物及其制备方法 | |
| CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN101342271B (zh) | 医治肿瘤化疗引起的气血两虚的中药及制备方法 | |
| CN105079533B (zh) | 一种用于降血糖的茶饮品及其制备方法 | |
| CN104740583A (zh) | 一种用于缓解克罗恩病的中药制剂及其制备方法 | |
| CN106389881A (zh) | 一种活血散瘀膏 | |
| CN104324330A (zh) | 一种治疗淤血蓄结型子宫肌瘤的中药组合物及其制备方法 | |
| CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
| CN106266548A (zh) | 治疗慢性胃炎的中药组合物、制备方法及其中药制剂 | |
| CN102475875B (zh) | 一种外用中药制剂及其生产方法 | |
| CN104258224A (zh) | 一种治疗肺肾阴虚型慢性支气管炎的五味子口服液及其制备方法 | |
| CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
| CN106267075A (zh) | 一种用于治疗强直性脊柱炎的中药胶囊 | |
| CN105770760A (zh) | 主治胃溃疡的制剂及其制备方法 | |
| CN1733101A (zh) | 治疗子宫内膜异位的中药 | |
| CN105169111A (zh) | 一种用于治疗慢性荨麻疹的中药组合物及其应用 | |
| CN106166205A (zh) | 治疗颈肩腰腿痛的中药组合物、制备方法及其中药制剂 | |
| CN120078871A (zh) | 一种治疗慢性腹泻的中药组合物及其应用 | |
| CN103816468B (zh) | 一种治疗胃癌的胶囊及其制备方法 | |
| CN104225311A (zh) | 神经衰弱补益心脾药剂及制法 | |
| CN106266459A (zh) | 治疗血栓性脉管炎的中药组合物、制备方法及其中药制剂 | |
| CN106237001A (zh) | 治疗骨科炎症的中药组合物、制备方法及其中药制剂 | |
| CN103845493A (zh) | 一种治疗急性腰扭伤的内服中药及其制备方法 | |
| CN106138661A (zh) | 治疗肝病的中药组合物、制备方法及其中药制剂 | |
| CN106214901A (zh) | 抗衰老的中药组合物、制备方法及其中药制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170104 |
|
| RJ01 | Rejection of invention patent application after publication |